Live Feeds

Source map — Lilly raises diabetes weight-loss bar with amylin-Zepbound combo

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
NBC News news 60%
CNBC news 60%
Eli Lilly news 60%
USA Today news 60%
Fierce Biotech news 60%
Yahoo news 60%
The Guardian news 60%
www.matterfact.com news 50%
pspeptides.com news 50%
finance.biggo.com news 50%
en.wikipedia.org news 50%
www.diabetes.co.uk news 50%
rocketnews.com news 50%
pharmaphorum.com news 50%
finance.yahoo.com news 50%
londondaily.com news 50%
www.trialsitenews.com news 50%
economictimes.indiatimes.com news 50%
madamenoire.com news 50%
worldattention.com news 50%
www.advisory.com news 50%
health.yahoo.com news 50%
primexbt.com news 50%
careers.lilly.com news 50%
updates.biomednexus.com news 50%
theclinicaltimes.com news 50%
www.onedayadvisor.com news 50%
joeymed.com news 50%
www.prnewswire.com news 50%
www.biospace.com news 50%
www.careyounews.org news 50%
www.medicaldaily.com news 50%